X

At Gilead, we Aspire to Advance HIV Care from Treatment and Prevention to Cure

For more than 25 years, Gilead Sciences has been at the forefront of advancing the care of people living with HIV by developing novel antiretroviral therapies. The evolution of HIV care since the early days of the HIV epidemic has helped to transform HIV infection from a fatal and debilitating disease into a chronic, manageable condition for many people. In further efforts to help end the HIV epidemic, Gilead continues to work across multiple fronts to discover new options to help treat and prevent HIV infection, help expand access to HIV testing and linkage to care, and conduct clinical research that could one day play a role in eradicating HIV infection.

Gilead Logo